-
Review
June 9, 2025
- Prospects of Mendelian randomization in hepatology: a comprehensive literature review with practice guidance
- Lanlan Chen, Qi Rao, Menghan Gao, et al.
- Clin Mol Hepatol. 2025;31(4):1115-1138.
Articles in E-pub version are posted online ahead of regular printed publication.
- Original Article
- Evaluating Treatment Response Thresholds for Cost-Effective Treatment in Metabolic-Associated Steatotic Liver Disease
- Eileen L. Yoon, Jeong-Yeon Cho, Huiyul Park, Mimi Kim, Ji-hyeon Park, Hye-Lin Kim, Dae Won Jun
- Received July 18, 2025 Accepted October 30, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0796 [Accepted]
-
View: 187 Download: 14
- Review Article
- Panomics in MASLD: Unravelling the drivers of disease heterogeneity
- Carlos José Pirola, Silvia Sookoian
- Received August 27, 2025 Accepted October 25, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0960 [Accepted]
-
View: 272 Download: 16
- Incretin-based therapies for Cardio-Kidney-Liver-Metabolic (CKLM) Disease: The role of the liver in the modern era of chronic disease management.
- Harendran Elangovan, Rohit Loomba, Mark Muthiah, Jörn Schattenberg, Ming Hua Zheng, Mazen Noureddin, Christos Mantzoros, Jacob George
- Received August 1, 2025 Accepted October 26, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0857 [Accepted]
-
View: 249 Download: 30
- Original Article
- Integrative Multi-Omics Profiling Identifies Infiltrative HCC as an Immunotherapy-Resistant Subtype with Distinct Molecular Features
- Won Suk Lee, Seonjeong Woo, Sung Hwan Lee, Gae Hoon Jo, Ilhwan Kim, Hyeyeong Kim, Chansik An, Sanghoon Jung, Gwangil Kim, Haeyoun Kang, Beodeul Kang, Jung Sun Kim, Ho Yeong Lim, Incheon Kang, Hannah Yang, So Jung Kong, Dahyeon Son, Dong Jun Shin, Woo Young Kwon, Da-Yeon Lee, Ju-Seog Lee, Junho Park, Youngsoo Kim, Sohyun Hwang, Chan Kim, Hong Jae Chon
- Received July 17, 2025 Accepted October 26, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0792 [Accepted]
-
View: 361 Download: 51
- Bacteroides eggerthii Ameliorates MASLD through Host–Microbe Signaling and Highlights 2-Hydroxyisocaproate as a Potential Effector
- Jiyi Choi, Moon Gyeong Yoon, Se Ha Jang, Geum Ok Baek, Hyun Sun Jung, Na-Rae Lee, Choong Hwan Lee, Ji Eun Han, Jae Youn Cheong, Jung Woo Eun, Soon Sun Kim
- Received May 4, 2025 Accepted October 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0475 [Accepted]
-
View: 634 Download: 90
- Special Issue
- 2025 KASL clinical practice guidelines for management of hepatitis C
- Eun Sun Jang, Nae Yun Heo, Jae Yoon Jeong, Jung Gil Park, Do Seon Song, Eun Ju Cho, Chang Hun Lee, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jung, on behalf of the Korean Association for the Study of the Liver (KASL)
- Received July 15, 2025 Accepted October 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0777 [Accepted]
-
View: 312 Download: 33
- Editorial
- Harmonized ACLF Prognostication with Explainable Machine Learning Models: Traversing from Counts to Composition
- Sagnik Biswas, Akash Roy
- Received October 8, 2025 Accepted October 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1154 [Accepted]
-
View: 287 Download: 14
- Review Article
- Stratifying Cholangiocarcinoma: Tumor Microenvironment, Molecular Drivers, and Novel Immunotherapeutic Approaches
- Cindy Xinqi Liu, Carmen Chak-Lui Wong
- Received August 8, 2025 Accepted October 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0889 [Accepted]
-
View: 532 Download: 41
- Original Article
- Gut microbiota-mediated berberine metabolism ameliorates cholestatic liver disease by suppressing 5-HT production
- Dianji Tu, Cheng Lu, Junfeng Guo, Qiao Chen, Xin Li, Yingjie Wang, Lulu Cheng, Hongfei Jiang, Jincheng Jian, Yusong Ge, Zhanjie Hou, Xiaojie Feng, Yunxuan Feng, Jianchun Zhou, Yuanyuan Lei, Hua Diao, Lei Ran, Yuanyuan Zhou, Zhengguo Xu, Jiyin Zhou, Bo Tang, Shiming Yang
- Received May 30, 2025 Accepted October 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0577 [Accepted]
-
View: 736 Download: 163
- Letter to the Editor
- Plasma Exchange and Abrogation of Monocyte Activation in Wilson’s Disease
- Kwon Yong Tak, Min Seo Park, Pil Soo Sung
- Received September 12, 2025 Accepted October 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1039 [Accepted]
-
View: 363 Download: 48
- Correspondence
- Correspondence to the editorial “ASB3 degrades the gateway to β-oxidation: on Hepatocytic ASB3 deficiency alleviates MASLD by decreasing ubiquitin-mediated CPT1A”
- Dongqin Yang, Yuli Lin, Chunhua Song, Ming Guan
- Received September 25, 2025 Accepted September 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1100 [Accepted]
-
View: 411 Download: 26
- Correspondence to the editorial on “Targeting the ASB3-CPT1A axis—a new player in combating metabolic dysfunction-associated steatotic liver disease (CHM-2025-1013)”
- Yuli Lin, Dongqin Yang, Zhihao Wu, Ming Guan, Chunhua Song
- Received September 23, 2025 Accepted September 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1086 [Accepted]
-
View: 408 Download: 18
- Correspondence to editorial on “Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation”
- Changze Hong, Jinjun Chen
- Received September 17, 2025 Accepted September 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1063 [Accepted]
-
View: 280 Download: 3
- Research Letter
- Fifteen-year impact of cholecystectomy on multiple organs
- Ming Zheng
- Received September 19, 2025 Accepted September 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1057 [Accepted]
-
View: 289 Download: 22
- Distinct TIME Modulation by Anti-PD-1/PD-L1, VEGF, and CTLA-4 Blockade Provides a Rationale for Triplet Therapy in HCC
- Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi
- Received September 8, 2025 Accepted September 19, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0983 [Accepted]
-
View: 476 Download: 54
- Editorial
- Rethinking ACLF Prognosis: Can Machine Learning Outperform Conventional Scores? Editorial on: Predictive Machine Learning Model in ICU Patients with Acute-on-Chronic Liver Failure and Two or More Organ Failures
- Jung Hee Kim
- Received September 15, 2025 Accepted September 17, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1053 [Accepted]
-
View: 445 Download: 25
- Letter to the Editor
- Letter to the editor: Clarifying Residual Drug Effects and Subgroup Outcomes in TDF-to-BSV Switch Trials
- Lihuang Su, Tongtong Pan
- Received September 11, 2025 Accepted September 17, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1034 [Accepted]
-
View: 369 Download: 13
- Reply to Correspondence
- Reply to "Correspondence to Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence Surveillance”
- Qi-Feng Chen, Sui-Xing Zhong, Xiong-Ying Jiang, Ming Zhao
- Received September 11, 2025 Accepted September 17, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1033 [Accepted]
-
View: 325 Download: 12
- Editorial
- ASB3 Degrades the Gateway to β-Oxidation: Editorial on “Hepatocytic ASB3 deficiency alleviates MASLD by decreasing ubiquitin-mediated CPT1A”
- Ho Jae Ryu, Ji Su Han, Ja Hyun Koo
- Received September 9, 2025 Accepted September 17, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1021 [Accepted]
-
View: 472 Download: 35
- Research Letter
- Non-Contrast MRI Outperforms Contrast-Enhanced CT in Preoperative Detection of Hepatocellular Carcinoma: A Paired Validation Study
- Laizhu Zhang, Weiwei Zong, Jialin Gao, Huan Li, Leizhou Xia, Xiaoli Mai, Jun Chen, Binghua Li, Decai Yu
- Received August 18, 2025 Accepted September 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0927 [Accepted]
-
View: 483 Download: 65
- Editorial
- Targeting the ASB3-CPT1A axis—a new player in combating metabolic dysfunction-associated steatotic liver disease
- Yueying Yang, Ying Yang, Yan Lu
- Received September 8, 2025 Accepted September 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.1013 [Accepted]
-
View: 769 Download: 28
- Correspondence
- Impaired fungal surveillance with Kennedy pathway activation drives acute liver failure, validated in preclinical models
- Neha Sharma, Sushmita Pandey, Shvetank Sharma, Shiv Kumar Sarin, Jaswinder Singh Maras
- Received August 29, 2025 Accepted September 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0970 [Accepted]
-
View: 304 Download: 18
- Original Article
- RAB25/GCN1 Signaling Promotes ER Stress to Mediate Alcohol-associated Liver Disease Progression
- Xue-Wen Liu, Zi-Bin Zhan, Ze-Hua Li, Yue Zhang, Xue-Yan Qiao, Xin-Ming Li, Xiang-Jing Liang, Kun-Hao Bai, Xian-Feng Xia, Fan-Hong Zeng, Yi Gao, Jun Weng
- Received May 28, 2025 Accepted September 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0559 [Accepted]
-
View: 1451 Download: 159
- Reply to Correspondence
- Reply to Correspondence to “Call for Preemptive Treatment of Cytomegalovirus in Patients with Cirrhosis and Acute Decompensation”
- Norihiro Imai
- Received August 27, 2025 Accepted August 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0963 [Accepted]
-
View: 1423 Download: 8
- Editorial
- An editorial on “Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation” by Hong et al. Title: Human cytomegalovirus reactivation in decompensated cirrhosis: marker of immunosuppression or contributor to severity?
- Zhujun Cao, Richard Moreau
- Received August 27, 2025 Accepted August 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0962 [Accepted]
-
View: 1404 Download: 22
- Correspondence
- Reply to Letter on “Sex-Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol-Related Cirrhosis in the U.S., 2021–2040”
- Pojsakorn Danpanichkul, Luis Antonio Diaz, Juan Pablo Arab, Amit G. Singal, Ju Dong Yang
- Received August 24, 2025 Accepted August 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0948 [Accepted]
-
View: 1385 Download: 10
- Correspondence to the letter titled “Beyond Diagnostic Accuracy: Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence Surveillance”
- Dong Ho Lee
- Received August 23, 2025 Accepted August 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0945 [Accepted]
-
View: 1176 Download: 12
- SAFE Score in Chronic Liver Diseases: A Tool for Risk Enrichment and Personalized Surveillance
- Tung-Hung Su, Jia-Horng Kao
- Received August 25, 2025 Accepted August 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0940 [Accepted]
-
View: 1145 Download: 11
- Letter to the Editor
- Correspondence to editorial on “Dysfunction in CD8+ T Cells in Early-Stage HCC” by Qin et al.: New Insights into HCC Immunotherapy
- Yang Kong, Xiaoqian Shen, Kun Xue, Haiying Wang
- Received August 4, 2025 Accepted August 22, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0880 [Accepted]
-
View: 1162 Download: 10
- Editorial
- Genome-wide SNP-BMI interaction analysis highlights CYP7A1 and GIPR as two novel genetic modifiers of MASLD
- Julia Kozlitina
- Received August 17, 2025 Accepted August 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0923 [Accepted]
-
View: 1319 Download: 16
- Correspondence
- Correspondence to editorial on “Human cytomegalovirus reactivation in cirrhosis patients with acute decompensation”
- Changze Hong, Jinjun Chen
- Received August 9, 2025 Accepted August 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0899 [Accepted]
-
View: 1929 Download: 7
- Letter to the Editor
- Sex‑Specific Trends and Demographic vs Epidemiologic Drivers of Alcohol‑Related Cirrhosis in United States, 2021–2040
- Kui Wang, Yunqing Zeng
- Received July 21, 2025 Accepted August 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0790 [Accepted]
-
View: 1290 Download: 33 Crossref: 1
- Review Article
- Harnessing the Microbiome: Unveiling the Influence of the Gut Microbiota on Hepatobiliary Cancer Therapeutic Strategies
- Melody Yusong Li, Xue Qian Wu, Terence Kin Wah Lee
- Received April 28, 2025 Accepted August 19, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0476 [Accepted]
-
View: 1558 Download: 53
- Letter to the Editor
- Plasma Lipidomic and Fungal Signatures Predict Early Mortality in Acute Liver Failure
- Yu Ji Kim, Jong-Won Kim
- Received July 22, 2025 Accepted August 18, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0813 [Accepted]
-
View: 1385 Download: 37
- Review
- Tumor-based biomarkers and circulating tumor DNA for precision medicine in advanced hepatocellular carcinoma
- Sabrina Sidali, Claudia Campani, Jihyun An, Ju Hyun Shim, Jean-Charles Nault
- Received July 8, 2025 Accepted August 18, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0746 [Accepted]
-
View: 1986 Download: 67
- Reply to Correspondence
- Reply to correspondence on: Methodological Concerns Regarding GLP-1RA Effects on MASLD Outcomes
- Xingyu Yao
- Received August 6, 2025 Accepted August 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0892 [Accepted]
-
View: 1259 Download: 14
- Correspondence
- Reply: Methodological Concerns Regarding GLP-1RA Effects on MASLD Outcomes
- Xianhua Mao, Mindie H Nguyen
- Received August 5, 2025 Accepted August 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0884 [Accepted]
-
View: 1210 Download: 13
- Reply to Correspondence
- Reply to correspondence on “Factors associated with hepatitis B mother-to-child transmission in a national prevention program”
- Eunho Choi, Ji Hoon Kim, Young-Sun Lee
- Received August 2, 2025 Accepted August 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0871 [Accepted]
-
View: 1326 Download: 12
- Letter to the Editor
- “Surrogates Without Substance?” Questioning the Evidence for Histologic Improvement With HTD1801
- Zhihao Lei
- Received August 1, 2025 Accepted August 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0868 [Accepted]
-
View: 1235 Download: 19
- Letter to the editor on “HTD1801 demonstrates promising potential for histologic improvements in metabolic dysfunction-associated steatohepatitis in both a preclinical and phase 2 study. ”
- Xi-Lin Gao
- Received July 21, 2025 Accepted August 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0804 [Accepted]
-
View: 1986 Download: 16
- Beyond Diagnostic Accuracy: Economic and Clinical Considerations for NC-MRI in Late HCC Recurrence Surveillance
- Qi-Feng Chen, Sui-Xing Zhong, Ming Zhao
- Received July 13, 2025 Accepted August 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0769 [Accepted]
-
View: 1269 Download: 42
- Review
- Pediatric metabolic dysfunction-associated steatotic liver disease and the gut microbiome: from research landscape to targeted modulation
- Lu Jiang, Lan-Duoduo Du, Jing Zeng, Hui-kuan Chu, Zhong Peng, Jian-Gao Fan
- Received July 2, 2025 Accepted August 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0718 [Accepted]
-
View: 3056 Download: 126
- Letter to the Editor
- Letter “GLP-1 RA and Reduced Liver and Non-Liver Complications in Adults with T2D and MASLD: A Target Trial Emulation Study”
- Chunyan Wang, Xu Han, Yinyan Li
- Received June 21, 2025 Accepted August 9, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0676 [Accepted]
-
View: 1431 Download: 27
- Comment on “High Steatosis-Associated Fibrosis Estimator Scores Predict Hepatocellular Carcinoma in Viral and Non-Viral Hepatitis and Metabolic Dysfunction-Associated Steatotic Liver Disease”
- Prajnasini Satapathy, Rachana Mehta, Ranjana Sah
- Received August 2, 2025 Accepted August 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0875 [Accepted]
-
View: 1884 Download: 16
- Reply to Correspondence
- Metabolic dysfunction-associated steatotic liver disease(MASLD): On track to become the dominant etiology of hepatocellular carcinoma
- Jian Xu, Wei Zhang, Guo Wu, Jingdong Li
- Received July 29, 2025 Accepted August 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0853 [Accepted]
-
View: 2207 Download: 35
- Editorial
- Call for Preemptive Treatment of Cytomegalovirus in Patients with Cirrhosis and Acute Decompensation
- Norihiro Imai
- Received July 26, 2025 Accepted August 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0840 [Accepted]
-
View: 1522 Download: 22
- Research Letter
- Early oxidative protein modifications and gut damage/leakiness contribute to drug-induced acute liver failure
- Wiramon Rungratanawanich, Ying Qu, Andrew Holmes, Neil Kaplowitz, Byoung-Joon Song
- Received July 8, 2025 Accepted July 30, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0748 [Accepted]
-
View: 1349 Download: 47
- Correspondence
- Correspondence to the editorial titled “HCC Surveillance After Curative Treatment: A New Frontier for Abbreviated MRI”
- Dong Ho Lee
- Received July 24, 2025 Accepted July 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0830 [Accepted]
-
View: 1278 Download: 3
- Correspondence to the letter titled “Revisiting the Role of Non-Contrast MRI in Recurrent HCC: Bridging Diagnostic Performance and Real-World Applicability”
- Dong Ho Lee
- Received July 24, 2025 Accepted July 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0829 [Accepted]
-
View: 1058 Download: 6
- Correspondence to editorial on “Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in MASLD”
- Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
- Received July 23, 2025 Accepted July 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0820 [Accepted]
-
View: 1900 Download: 16 Crossref: 1
- Correspondence to editorials (CMH-2025-0699) on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
- Woo Hyun Paik, Heon Se Jeong, Do Hyun Park
- Received July 22, 2025 Accepted July 27, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0816 [Accepted]
-
View: 1541 Download: 14
- Correspondence to editorial on “Factors associated with hepatitis B mother-to-child transmission in a national prevention program”: Redefining MTCT prevention strategies toward HBV elimination
- Moran Ki, Jong-Hyun Kim
- Received July 21, 2025 Accepted July 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0805 [Accepted]
-
View: 1157 Download: 24
- Research Letter
- Contemporary Trends in Extrahepatic Mortality of Chronic Liver Disease in the United States from 2014 to 2023
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Aijaz Ahmed
- Received July 23, 2025 Accepted July 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0802 [Accepted]
-
View: 1660 Download: 31
- Editorial
- Breaking the Chain of Perinatal Hepatitis B Transmission
- Shang-Chin Huang, Jia-Horng Kao
- Received July 20, 2025 Accepted July 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0801 [Accepted]
-
View: 1247 Download: 9
- HCC Surveillance After Curative Treatment: A New Frontier for Abbreviated MRI Editorial on: “Non-contrast MRI for Detection of Late Recurrent Hepatocellular Carcinoma After Curative Treatment: Comparison to CT”
- Hyungjin Rhee, Jin-Young Choi
- Received July 16, 2025 Accepted July 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0786 [Accepted]
-
View: 1198 Download: 32
- Letter to the Editor
- Letter: Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity
- Qicong Mai, Jianming Zheng, Meishi Tang, Yubin Liu
- Received July 9, 2025 Accepted July 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0757 [Accepted]
-
View: 1296 Download: 19
- Letter “Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunction-associated steatotic liver disease”
- Xinyi Cai, Lu Zhang, Tuo Li
- Received July 3, 2025 Accepted July 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0731 [Accepted]
-
View: 2261 Download: 19
- Revisiting the Role of Non-Contrast MRI in Recurrent HCC: Bridging Diagnostic Performance and Real-World Applicability
- Lu Sun, Xin Zhang
- Received June 24, 2025 Accepted July 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0683 [Accepted]
-
View: 1190 Download: 34
- Letter: Methodological Concerns Regarding GLP-1RA Effects on MASLD Outcomes
- Xingyu Yao
- Received June 11, 2025 Accepted July 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0620 [Accepted]
-
View: 1329 Download: 24 Crossref: 1
- Correspondence
- Response to Editorial on Ciociola et al., "Downregulation of the MARC1 p.A165 Risk Allele Reduces Hepatocyte Lipid Content by Increasing Beta-Oxidation"
- Ester Ciociola, Tanmoy Dutta, Rosellina M. Mancina, Stefano Romeo
- Received July 11, 2025 Accepted July 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0765 [Accepted]
-
View: 1314 Download: 19
- Correspondence to “Critical Flaws in the Molecular Classification of HCC Based on Metabolic Zonation”
- Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
- Received July 10, 2025 Accepted July 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0760 [Accepted]
-
View: 1449 Download: 10
- Editorial
- Redefining MTCT prevention strategies toward HBV elimination: Editorial on “Factors associated with hepatitis B mother-to-child transmission in a national prevention program”
- Eunho Choi, Ji Hoon Kim, Young-Sun Lee
- Received July 8, 2025 Accepted July 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0747 [Epub ahead of print]
-
View: 1801 Download: 19
- Clinical implications of residual changes following HCV clearance
- So-Young Kim, Eui-Cheol Shin
- Received July 3, 2025 Accepted July 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0728 [Accepted]
-
View: 1309 Download: 22
- Letter to the Editor
- Letter to the editor on” Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial. ”
- Bitao Jiang, Song Zhang, Lingling Bao
- Received June 28, 2025 Accepted July 10, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0699 [Accepted]
-
View: 1520 Download: 24
- Reconsidering the Role of Plasma pgRNA in NUC-treated CHB: Stratified Biomarker Interpretation and the Limits of Current Assays
- Xu Han, Jun Sun, Yinyan Li
- Received June 16, 2025 Accepted July 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0642 [Accepted]
-
View: 1100 Download: 18
- Editorial
- Opportunities and challenges in controlling metabolic dysfunction-associated steatotic liver disease (MASLD): Editorial on “Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation”
- Jian Xu, Gang Shi, Tao Sheng, Jingdong Li
- Received June 30, 2025 Accepted July 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0708 [Accepted]
-
View: 1748 Download: 38
- Correspondence
- Correspondence to editorial on “GLP-1RA may open a new era for MASLD treatment”
- Xianhua Mao, Mindie H Nguyen
- Received June 29, 2025 Accepted July 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0705 [Accepted]
-
View: 1707 Download: 18
- Reply: Early Cancer Risk Reduction After GLP-1RA Use: Signal or Bias?
- Xianhua Mao, Mindie H Nguyen
- Received June 29, 2025 Accepted July 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0704 [Accepted]
-
View: 1064 Download: 13
- Editorial
- The other face of GWAS: Editorial on “Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD”
- Hyungtai Sim, Murim Choi
- Received June 22, 2025 Accepted July 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0677 [Accepted]
-
View: 1307 Download: 26
- Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunctionassociated steatotic liver disease”: Rethinking first-line screening in MASLD: beyond the limitations of Fibrosis-4 index
- Han Ah Lee, Young Youn Cho, Hyung Joon Kim
- Received June 23, 2025 Accepted June 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0678 [Accepted]
-
View: 2029 Download: 25
- Letter to the Editor
- Letter"Novel Genetic Modulators of MASLD Identified Through Genome-Wide Interaction with BMI"
- Sheng Zheng
- Received June 18, 2025 Accepted June 26, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0656 [Accepted]
-
View: 1205 Download: 22
- Correspondence
- Correspondence to letter to the editor on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
- Hye Won Lee, Seung Up Kim
- Received June 17, 2025 Accepted June 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0644 [Accepted]
-
View: 2410 Download: 15
- Editorial
- GLP-1RA may open a new era for MASLD treatment
- Ye Feng, Chengfu Xu
- Received June 12, 2025 Accepted June 19, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0628 [Accepted]
-
View: 1506 Download: 63
- Letter to the Editor
- Critical Flaws in the Molecular Classification of HCC Based on Metabolic Zonation
- Yongzhi Xie, Xiangyu Zhu, Qi Liang
- Received June 9, 2025 Accepted June 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0610 [Accepted]
-
View: 1363 Download: 38
- Reply to Correspondence
- Correspondence on “Reply to "Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers"”
- Dibin Liu
- Received June 8, 2025 Accepted June 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0604 [Accepted]
-
View: 1499 Download: 29
- Correspondence
- Reply to the letter to the editor on “Re: “Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States”
- Pojsakorn Danpanichkul, Luis Antonio Diaz, Juan Pablo Arab, Amit G. Singal, Ju Dong Yang
- Received June 5, 2025 Accepted June 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0594 [Accepted]
-
View: 1629 Download: 16 Crossref: 2
- Reply to the letter：Advancing the Baveno VI-SSM Model for Clinical Utility in HBV-Related Cirrhosis
- Haiyu Wang, Jinjun Chen
- Received June 9, 2025 Accepted June 10, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0611 [Accepted]
-
View: 1171 Download: 4
- Letter to the Editor
- Letter “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
- Jun Sun, Xu Han, Yinyan Li
- Received June 2, 2025 Accepted June 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0586 [Accepted]
-
View: 1687 Download: 34
- Re: “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
- Bitao Jiang, Lingling Bao
- Received June 1, 2025 Accepted June 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0584 [Accepted]
-
View: 1669 Download: 37
- Early Cancer Risk Reduction After GLP-1RA Use: Signal or Bias?”
- Shio-Shin Jean, Chih-Cheng Lai
- Received May 31, 2025 Accepted June 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0583 [Accepted]
-
View: 1239 Download: 40
- Letter "Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease"
- Chunyan Wang, Jun Sun, Yinyan Li
- Received May 16, 2025 Accepted June 5, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0539 [Accepted]
-
View: 2345 Download: 26
- Reply to Correspondence
- Reply to correspondence on “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”
- Heejoon Jang, Won Kim
- Received May 14, 2025 Accepted June 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0533 [Accepted]
-
View: 1715 Download: 13
- Reply to correspondence on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
- Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Received May 26, 2025 Accepted May 30, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0564 [Accepted]
-
View: 2015 Download: 21
- Reply to correspondence on “Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States”
- Sung-Eun Kim
- Received May 15, 2025 Accepted May 30, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0536 [Accepted]
-
View: 1457 Download: 18
- Letter to the Editor
- Letter “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Bo Zheng, Lizhou Wang
- Received May 11, 2025 Accepted May 31, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0521 [Accepted]
-
View: 1596 Download: 28
- Reply to Correspondence
- Reply to correspondence on “Unveiling TRIB3: A New Mediator in MET-Driven Hepatocellular Carcinoma Progression
- Many Sze Man Chan, Terence Kin Wah Lee
- Received May 14, 2025 Accepted May 30, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0530 [Accepted]
-
View: 1599 Download: 13
- Letter to the Editor
- Re: “Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States”
- Dibin Liu
- Received May 15, 2025 Accepted May 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0537 [Accepted]
-
View: 1376 Download: 28
- Correspondence
- Advancing policy and practice in alcohol-associated liver disease and alcohol-attributable cancer: Correspondence to the editorial on “Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States”
- Pojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, Amit G. Singal, Ju Dong Yang
- Received May 13, 2025 Accepted May 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0527 [Epub ahead of print]
-
View: 2798 Download: 11
- Correspondence to Editorial 2 on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
- Tiantian Wang, Wenjie Huang, Limin Xia
- Received May 13, 2025 Accepted May 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0523 [Epub ahead of print]
-
View: 2919 Download: 18
- Editorial
- Rising Burden of Alcohol-Associated Liver Disease and Cancers: Insights into Sex Disparities and Policy Implications
- Sung-Eun Kim
- Received May 9, 2025 Accepted May 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0516 [Accepted]
-
View: 1470 Download: 17 Crossref: 2
- Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma
- Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Received May 9, 2025 Accepted May 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0515 [Accepted]
-
View: 2027 Download: 59 Crossref: 1
- Correspondence
- Correspondence to Editorial 1 on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
- Tiantian Wang, Wenjie Huang, Limin Xia
- Received May 6, 2025 Accepted May 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0507 [Epub ahead of print]
-
View: 2945 Download: 19
- Reply to Correspondence
- Advancing metabolic risk profiling in chronic hepatitis B: Reply to correspondence on “Metabolic health in antiviral era of chronic hepatitis B”
- Shang-Chin Huang, Jia-Horng Kao
- Received May 4, 2025 Accepted May 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0500 [Epub ahead of print]
-
View: 2434 Download: 18
- Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
- Eun Ji Jang, Pil Soo Sung
- Received May 3, 2025 Accepted May 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0498 [Epub ahead of print]
-
View: 2784 Download: 16
- Correspondence
- Correspondence to editorial “Metabolic health in antiviral era of chronic hepatitis B”
- Rui Huang, Mindie H. Nguyen
- Received April 29, 2025 Accepted May 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0479 [Accepted]
-
View: 1966 Download: 4
- Correspondence to editorial “Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B”
- Rui Huang, Mindie H. Nguyen
- Received April 29, 2025 Accepted May 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0478 [Accepted]
-
View: 1513 Download: 5
- Correspondence to editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
- Hye Won Lee, Seung Up Kim
- Received April 29, 2025 Accepted May 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0477 [Epub ahead of print]
-
View: 3452 Download: 7
- Letter to the Editor
- Molecular stratification of hepatocellular carcinoma by metabolic-signaling pathways guides precision immunotherapy and TACE therapy
- Binghua Li, Yanchao Xu, Yican Zhu, Yukun Zhang, Zijie Wu, Tianci Luo, Laizhu Zhang, Weiwei Hu, Decai Yu
- Received March 27, 2025 Accepted April 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0344 [Epub ahead of print]
-
View: 2626 Download: 111 Crossref: 2
- Editorial
- Unveiling TRIB3: A new mediator in MET-driven hepatocellular carcinoma progression: Editorial on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”
- Many Sze Man Chan, Terence Kin Wah Lee
- Received April 23, 2025 Accepted April 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0452 [Epub ahead of print]
-
View: 2825 Download: 37 Crossref: 1
- Correspondence
- Correspondence to editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
- Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
- Received April 18, 2025 Accepted April 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0435 [Epub ahead of print]
-
View: 2968 Download: 19 Crossref: 1
- Editorial
- Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis B
- Heejoon Jang, Won Kim
- Received April 16, 2025 Accepted April 25, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0430 [Accepted]
-
View: 2005 Download: 35
- Risk stratification of metabolic dysfunction-associated steatotic liver disease: The KASL pathway: Editorial on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
- May Xuan Goh, Xin En Goh, Jarell Jie-Rae Tan, Vincent L Chen, Yu Jun Wong
- Received April 14, 2025 Accepted April 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0420 [Epub ahead of print]
-
View: 3352 Download: 30 Crossref: 1
- Reply to Correspondence
- GULP1: New Hope for Hepatocellular Carcinoma: Reply to Correspondence on “GULP1 as a Novel Biomarker in HCC”
- Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen
- Received April 14, 2025 Accepted April 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0415 [Accepted]
-
View: 1359 Download: 21
- Correspondence
- Correspondence to editorial on “CD36 Promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in early-stage hepatocellular carcinoma”
- Yifei Qin, Peng Lin, Huijie Bian, Zhi-Nan Chen, Jiao Wu
- Received April 11, 2025 Accepted April 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0402 [Epub ahead of print]
-
View: 4025 Download: 38
- Letter to the Editor
- Letter to the editor on “Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target”
- Yuqian Liu, Ruiyun Guo, Jun Ma
- Received April 6, 2025 Accepted April 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0377 [Epub ahead of print]
-
View: 2797 Download: 58
- Editorial
- A Novel Link Between Tumor Cell Metabolism and Patient Prognosis: Editorial on “Molecular Classification of Hepatocellular Carcinoma based on Zoned Metabolic Feature and Oncogenic Signaling Pathway”
- Eun Ji Jang, Pil Soo Sung
- Received April 9, 2025 Accepted April 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0395 [Accepted]
-
View: 1683 Download: 14 Crossref: 2
- Reply to Correspondence
- Reply to correspondence on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Mathias Jachs, Mattias Mandorfer
- Received April 9, 2025 Accepted April 14, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0391 [Epub ahead of print]
-
View: 2833 Download: 16
- Correspondence
- Correspondence to editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”
- Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Jin Mo Yang
- Received April 7, 2025 Accepted April 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0379 [Epub ahead of print]
-
View: 2684 Download: 23
- Editorial
- Metabolic health in antiviral era of chronic hepatitis B: Editorial on “Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues”
- Shang-Chin Huang, Jia-Horng Kao
- Received April 3, 2025 Accepted April 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0369 [Epub ahead of print]
-
View: 2758 Download: 30
- Viral manipulation of host cell glutamine metabolism and glutamine rewiring in hepatic diseases: Editorial on “Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome”
- Mehrangiz Dezhbord, Kyun-Hwan Kim
- Received April 2, 2025 Accepted April 8, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0366 [Epub ahead of print]
-
View: 2317 Download: 68
- Correspondence
- Revisiting unmet needs in clinical research on direct-acting antiviral therapy for HCC patients: Correspondence to letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
- Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming- Lung Yu
- Received April 2, 2025 Accepted April 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0362 [Epub ahead of print]
-
View: 3044 Download: 19
- Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”
- Soon Sun Kim, Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun
- Received March 28, 2025 Accepted April 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0350 [Accepted]
-
View: 1410 Download: 17
- Editorial
- Targeting CD36 to reinvigorate CD8+ T Cells in early-stage hepatocellular carcinoma
- Valerie Chew
- Received March 25, 2025 Accepted March 28, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0334 [Accepted]
-
View: 2427 Download: 57 Crossref: 1
- Correspondence
- Correspondence to editorial 3 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Haiyu Wang, Jinjun Chen
- Received March 23, 2025 Accepted March 28, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0328 [Epub ahead of print]
-
View: 2880 Download: 11
- Correspondence to editorial 2 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Haiyu Wang, Jinjun Chen
- Received March 23, 2025 Accepted March 28, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0327 [Epub ahead of print]
-
View: 2668 Download: 10
- Correspondence to editorial 1 on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Haiyu Wang, Jinjun Chen
- Received March 23, 2025 Accepted March 28, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0326 [Epub ahead of print]
-
View: 2614 Download: 17
- Editorial
- GULP1, A Multifaceted Diagnostic Biomarker and Potential Therapeutic Target in Hepatocellular Carcinoma: Editorial on “GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma”
- Yuhao Xie, Lu-Qi Cao, John Wurpel, Zhe-Sheng Chen
- Received March 18, 2025 Accepted March 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0315 [Accepted]
-
View: 1956 Download: 39
- Besifovir: a viable option for long-term disease control in chronic hepatitis B: Editorial on “Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial”
- Wai-Kay Seto
- Received March 15, 2025 Accepted March 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0305 [Epub ahead of print]
-
View: 2173 Download: 23 Crossref: 1
- Refining portal hypertension assessment: The clinical significance of spleen stiffness measurement in the Baveno VII Era: Editorial on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Do Seon Song
- Received March 13, 2025 Accepted March 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0296 [Epub ahead of print]
-
View: 2250 Download: 51 Crossref: 2
- Letter to the Editor
- Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: a nationwide cohort study”
- Qiong Wang, Zhongqing Qian, Xiaodi Yang, Deyan Chen, Xiaojing Wang, Fuliang Chen
- Received March 13, 2025 Accepted March 19, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0291 [Epub ahead of print]
-
View: 3051 Download: 30 Crossref: 1
- Correspondence
- Correspondence to letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- Hyung Seok Kim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Received March 12, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0287 [Epub ahead of print]
-
View: 3444 Download: 33
- Editorial
- Unveiling GULP1 as a hepatocyte-specific role for recurrence: Editorial on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- Pengde Lu, Ning Wang
- Received March 11, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0282 [Epub ahead of print]
-
View: 2530 Download: 30
- vibraA non-invasive risk stratification tool for hepatitis B-related liver cirrhosis: The Baveno VI-SSM combined model: Editorial on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Ruiling He, Bingtian Dong, Xiaolong Qi
- Received March 11, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0281 [Epub ahead of print]
-
View: 2453 Download: 58 Crossref: 2
- Predicting decompensation risk in compensated HBV cirrhosis: Eternal sunshine for a spotless mind?: Editorial on “Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis”
- Mathias Jachs, Mattias Mandorfer
- Received March 11, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0280 [Epub ahead of print]
-
View: 2787 Download: 31 Crossref: 1
- The evolution of non-invasive strategies in cirrhosis management—from screening to precision monitoring: Editorial on “Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study”
- Haiyu Wang, Jinjun Chen
- Received March 9, 2025 Accepted March 15, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0274 [Epub ahead of print]
-
View: 2809 Download: 40
- Letter to the Editor
- Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangitis: Letter to the editor on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”
- Yizi He, Haifeng He, Qi Liang, Yongzhi Xie
- Received March 1, 2025 Accepted March 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0239 [Epub ahead of print]
-
View: 2661 Download: 37
- Reply to Correspondence
- SHOULD DIRECT-ACTING ANTIVIRAL BE CONSIDERED FOR ALL PATIENTS WITH HCV-RELATED HEPATOCELLULAR CARCINOMA?
- Yan Ling ONG, Apichat KAEWDECH, Yu Jun WONG
- Received March 5, 2025 Accepted March 10, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0257 [Accepted]
-
View: 1324 Download: 19
- Editorial
- Modulation of PRL-1 in placental MSCs: A novel therapeutic strategy for hepatic fibrosis: Editorial on “Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis”
- Lihai Jiang, Wenjie Zheng
- Received March 5, 2025 Accepted March 9, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0264 [Epub ahead of print]
-
View: 2672 Download: 34
- Regulation of hepatitis B virus cccDNA by metabolic pathways: Editorial on “GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome”
- Hyeong-Jin Cho, Sung-Gyoo Park
- Received March 4, 2025 Accepted March 9, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0255 [Epub ahead of print]
-
View: 3051 Download: 67 Crossref: 1
- Letter to the Editor
- Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”
- Juan Yang, Xinyi Li, Sheng Zheng
- Received February 24, 2025 Accepted March 5, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0216 [Epub ahead of print]
-
View: 3211 Download: 71 Crossref: 1
- Letter to the editor on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”
- Sisi Yang, Zhenxuan Ma
- Received February 11, 2025 Accepted March 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0153 [Epub ahead of print]
-
View: 3184 Download: 28
- Correspondence
- Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage: Correspondence to editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
- Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming-Lung Yu
- Received February 28, 2025 Accepted March 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0235 [Epub ahead of print]
-
View: 3000 Download: 27 Crossref: 1
- HCC predictors in routine practice for patients with chronic liver diseases: Correspondence to editorial on “High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease”
- Tung-Hung Su, Jia-Horng Kao
- Received February 18, 2025 Accepted February 22, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0187 [Epub ahead of print]
-
View: 2632 Download: 15
- Editorial
- Editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”
- Yan Ling Ong, Apichat Kaewdech, Daniel Q Huang, Yu Jun Wong
- Received February 14, 2025 Accepted February 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0174 [Epub ahead of print]
-
View: 3212 Download: 41 Crossref: 1
- Can SAFE score be utilized as a universal hepatocellular carcinoma prediction score?: Editorial on “High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease”
- Michael Kwan-Lung Ko, Loey Lung-Yi Mak
- Received February 3, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0118 [Epub ahead of print]
-
View: 2840 Download: 32
- Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on “High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease”
- Ho Soo Chun, Minjong Lee
- Received February 2, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0116 [Epub ahead of print]
-
View: 4140 Download: 26
